Cargando…

Shigella Bacteremia in a Patient with Visceral Leishmaniasis

Bacteremia due to Shigella is rare. A 26-year-old HIV-negative male presented with a persistent high-grade fever of two months duration to the Leishmaniasis Research and Treatment Center of University of Gondar Hospital. He was anorexic and had lost significant weight (from 76 to 57 kg in 4 months,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Endris, Mengistu, Mohammed, Rezika, Takele, Yegnasew, Woldeyohannes, Desalegn, Tiruneh, Moges, Diro, Ermias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010035/ https://www.ncbi.nlm.nih.gov/pubmed/24829834 http://dx.doi.org/10.1155/2013/920729

Ejemplares similares

Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Endris, Mengistu, et al.
Publicado: (2014)

Prevalence of malnutrition and associated risk factors among adult visceral leishmaniasis patients in Northwest Ethiopia: a cross sectional study
por: Mengesha, Bewketu, et al.
Publicado: (2014)

Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study
por: Diro, Ermias, et al.
Publicado: (2015)

Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
por: van Griensven, Johan, et al.
Publicado: (2018)

Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management
por: Ferede, Getachew, et al.
Publicado: (2017)

Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia
por: Vogt, Florian, et al.
Publicado: (2018)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia
por: Hailu, Workagegnehu, et al.
Publicado: (2021)

Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2020)

Case Report: Atypical Presentation of Visceral Leishmaniasis: Two Cases from Northwest Ethiopia
por: Mohammed, Rezika, et al.
Publicado: (2021)

High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia
por: Diro, Ermias, et al.
Publicado: (2014)

Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
por: Tajebe, Fitsumbrhan, et al.
Publicado: (2017)

Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration
por: Mohammed, Rezika, et al.
Publicado: (2021)

Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer
por: Fikre, Helina, et al.
Publicado: (2023)

Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study
por: Abongomera, Charles, et al.
Publicado: (2017)

Correction: Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV Infection
por: Takele, Yegnasew, et al.
Publicado: (2013)

Trend Analysis of Visceral Leishmaniasis at Addis Zemen Health Center, Northwest Ethiopia
por: Wondimeneh, Yitayih, et al.
Publicado: (2014)

Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production
por: Adem, Emebet, et al.
Publicado: (2016)

Visceral Leishmaniasis and HIV Coinfection in East Africa
por: Diro, Ermias, et al.
Publicado: (2014)

Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions
por: Yizengaw, Endalew, et al.
Publicado: (2016)

Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
por: Abongomera, Charles, et al.
Publicado: (2017)

Anticipating visceral leishmaniasis epidemics due to the conflict in Northern Ethiopia
por: Boodman, Carl, et al.
Publicado: (2023)

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines
por: van Griensven, Johan, et al.
Publicado: (2014)

Shigella flexneri perinephric abscess and bacteremia
por: Al Soub, Hussam, et al.
Publicado: (2005)

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
por: Tamiru, Aschalew, et al.
Publicado: (2016)

Prevalence of vancomycin resistant Enterococci and associated risk factors among clients with and without HIV in Northwest Ethiopia: a cross-sectional study
por: Abebe, Wondwossen, et al.
Publicado: (2014)

Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia
por: Franssen, Susanne U., et al.
Publicado: (2021)

Bacterial Isolates and Their Antimicrobial Susceptibility Patterns of Wound Infections among Inpatients and Outpatients Attending the University of Gondar Referral Hospital, Northwest Ethiopia
por: Mohammed, Aynalem, et al.
Publicado: (2017)

Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study
por: Diro, Ermias, et al.
Publicado: (2015)

Following successful anti-leishmanial treatment, neutrophil counts, CD10 expression and phagocytic capacity remain reduced in visceral leishmaniasis patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2022)

Infant feeding practice and associated factors of HIV positive mothers attending prevention of mother to child transmission and antiretroviral therapy clinics in Gondar Town health institutions, Northwest Ethiopia
por: Muluye, Dagnachew, et al.
Publicado: (2012)

Active trachoma and associated risk factors among children in Baso Liben District of East Gojjam, Ethiopia
por: Ketema, Kassahun, et al.
Publicado: (2012)

Impaired in vitro Interferon-γ production in patients with visceral leishmaniasis is improved by inhibition of PD1/PDL-1 ligation
por: Takele, Yegnasew, et al.
Publicado: (2022)

Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus–Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial
por: Diro, Ermias, et al.
Publicado: (2018)

Shigella sonnei Bacteremia Presenting with Profound Hepatic Dysfunction
por: Shogbesan, Oluwaseun, et al.
Publicado: (2017)

Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2013)

Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
por: Takele, Yegnasew, et al.
Publicado: (2021)

Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
por: Aderie, Endashaw M., et al.
Publicado: (2017)

Shigella Bacteremia in an Immunocompetent Patient
por: Rotramel, Hayden E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7nqaq0mk4odvgeco92g3lol9bk